Kingsville, TX (PRWEB) September 23, 2011
Sensitive radiopharmaceuticals to detect and potentially treat heart disease present unique cold chain shipping challenges that will be addressed in a case study at the IQPC 9th Cold Chain & Temperature Management Global Forum in Philadelphia September 26 - 30.
David W. Mueller, CEO, Clear Vascular, Inc. will show how he successfully ships a temperature-sensitive, radioactive product and human tissue between the northern and southern hemispheres, enduring wide seasonal temperature variations, erratic delivery schedules, delays, and long shipment times. Intelligent Thermal Solutions’ EcoTherm R11 container provides “intelligent cooling” to meet the specific requirements to preserve the radioisotope and the protein.
Dr. Mueller will be among nearly 50 industry-leading speakers delivering presentations on more efficient, flexible and visible supply chains to combat today's and tomorrow's pressures.
Intelligent Thermal Solutions makes five-day temperature-assured cold chain containers for safely shipping pharmaceuticals and biologics worldwide. Eco-Therm™ containers can be reused up to 100 times, versus once for typical corrugated boxes and packaging, dramatically reducing materials headed for landfills. The Intelligent Thermal Solutions depot system eliminates the cost of return logistics.
ITS earned two 2011 Greener Package Awards for Environmental Impact and Innovator of the Year. For more information about ITS, visit http://www.intelligentthermalsolutions.com.
About Intelligent Thermal Solutions
Intelligent Thermal Solutions, LLC is a south Texas company headquartered in Kingsville, TX, previously known as Active CC Boxes LLC. The technology in EcoTherm™ containers was recognized with the 2002 DuPont Gold Award for packaging design innovation for cold chain, and the 2002 R&D 100 Awards recognizing the 100 most technologically-significant products of 2002.
About Clear Vascular
Clear Vascular, Inc., a medical pharmaceutical company, develops pharmaceutical products for the treatment of cardiovascular conditions. The company’s products include an injectable radiopharmaceutical for imaging heart disease. Clear Vascular, Inc. was founded in 2005 and is based in New York, New York.